Clinical Trial Update: Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes an ongoing presurgical Phase II study of talazoparib in combination with enzalutamide for prostate cancer, currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Talzenna (talazoparib)
• Xtandi (enzalutamide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING